Death certificates compared to SEER-Medicare data for surveillance of liver cancer mortality due to hepatitis B or hepatitis C infection.

Jiang, Joy J; Shiels, Meredith S; O'Brien, Thomas R

Jiang, Joy J; Shiels, Meredith S; O'Brien, Thomas R.

Affiliation

Jiang JJ; Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Shiels MS; Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
O'Brien TR; Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.

J Viral Hepat ; 28(6): 934-941, 2021 06.

Article in En | MEDLINE | ID: mdl-33720473

Subject(s)

Carcinoma, Hepatocellular; Hepatitis B; Hepatitis C; Liver Neoplasms; Aged; Carcinoma, Hepatocellular/epidemiology; Death Certificates; Hepatitis B/complications; Hepatitis B/epidemiology; Hepatitis C/complications; Hepatitis C/epidemiology; Humans; Liver Neoplasms/epidemiology; Medicare; United States/epidemiology

Key words

cause of death; hepatitis B virus; hepatitis C virus; liver cancer; surveillance

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Hepatitis C / Carcinoma, Hepatocellular / Hepatitis B / Liver Neoplasms Type of study: Screening_studies Limits: Aged / Humans Country/Region as subject: America do norte Language: En Year: 2021 Type: Article

Fulltext

XML

PubMed Links

Search on Google